Quest Diagnostics Incorporated logo

Quest Diagnostics IncorporatedNYSE: DGX

Profile

Sector:

Healthcare

Country:

United States

IPO:

17 December 1996

Next earnings report:

31 January 2025

Last dividends:

04 October 2024

Next dividends:

14 January 2025
$17.99 B
-14%vs. 3y high
95%vs. sector
0%vs. 3y high
38%vs. sector
-20%vs. 3y high
66%vs. sector
-1%vs. 3y high
37%vs. sector

Price

after hours | Tue, 19 Nov 2024 23:11:50 GMT
$161.16-$0.95(-0.59%)
$2.49 B$2.57 B
$2.49 B$226.00 M

Analysts recommendations

Institutional Ownership

DGX Latest News

All You Need to Know About Quest Diagnostics (DGX) Rating Upgrade to Buy
zacks.com13 November 2024 Sentiment: POSITIVE

Quest Diagnostics (DGX) has received a Zacks Rank #2 (Buy) upgrade, indicating increased confidence in the company's potential earnings. This could lead to a rise in the stock price soon.

Is Quest Diagnostics Stock a Smart Addition to Your Portfolio Now?
zacks.com13 November 2024 Sentiment: POSITIVE

DGX shows strong performance in its core business. The growing use of the Advanced Diagnostics service is also a good sign.

Quest Diagnostics Declares Quarterly Cash Dividend
prnewswire.com12 November 2024 Sentiment: POSITIVE

SECAUCUS, N.J., Nov. 12, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a top company in diagnostic information services, has announced that its Board of Directors has approved a quarterly cash dividend of $0.75 per share. This dividend will be paid on January 29, 2025, to shareholders who own Quest Diagnostics common stock as of January 14, 2025.

DGX vs. PNTG: Which Stock Is the Better Value Option?
zacks.com11 November 2024 Sentiment: NEUTRAL

Investors who focus on Medical - Outpatient and Home Healthcare stocks probably know about Quest Diagnostics (DGX) and The Pennant Group, Inc. (PNTG). However, which of these companies is the better choice for those seeking undervalued stocks?

Quest Diagnostics Incorporated (DGX) Soars to 52-Week High, Time to Cash Out?
zacks.com25 October 2024 Sentiment: POSITIVE

Quest Diagnostics (DGX) has reached its highest point in the last year, but can investors expect further growth? We will examine the company's fundamentals for insights.

Quest Diagnostics Has Massive Secular Tailwinds And A Strong Base
seekingalpha.com24 October 2024 Sentiment: POSITIVE

Quest Diagnostics is seeing more lab tests, especially in genetic testing, due to an older population, and it provides a 2.0% dividend yield. The company's strategy for mergers and acquisitions, like buying LifeLabs, is designed to grow its presence and diversify its services, even though it may temporarily lower earnings per share. While there are risks from reimbursement cuts and labor market issues, Quest Diagnostics anticipates long-term growth from both its own efforts and acquisitions.

Quest Diagnostics: Organic Growth Leads To Q3 Earnings Beat
seekingalpha.com24 October 2024 Sentiment: POSITIVE

Quest Diagnostics announced impressive earnings for the third quarter, showing an 8.5% increase in revenue and a 3.6% rise in diluted earnings per share, surpassing analysts' predictions. The company has also updated its revenue forecast for 2024, anticipating strong growth from recent and future acquisitions, with expectations of double-digit revenue growth in the fourth quarter. Although there are concerns about economic challenges and inflation, I remain optimistic about DGX, changing my Buy Threshold to $150 and my Sell Target to $227.

Quest Diagnostics (DGX) Q3 2024 Earnings Call Transcript
seekingalpha.com22 October 2024 Sentiment: POSITIVE

Quest Diagnostics Incorporated (NYSE:DGX) will hold its Q3 2024 Earnings Conference Call on October 22, 2023, at 8:30 AM ET. The call will feature company leaders, including President and CEO Jim Davis, along with several financial analysts from various firms. This call is being recorded at the company's request.

DGX Stock Rises on Q3 Earnings and Revenue Beat, 2024 Sales View Up
zacks.com22 October 2024 Sentiment: POSITIVE

Quest Diagnostics' results for the third quarter of 2024 show strong growth in their DIS business and positive impacts from recent acquisitions.

Quest Diagnostics (DGX) Beats Q3 Earnings and Revenue Estimates
zacks.com22 October 2024 Sentiment: POSITIVE

Quest Diagnostics (DGX) reported quarterly earnings of $2.30 per share, which is higher than the Zacks Consensus Estimate of $2.26 per share. This is an increase compared to earnings of $2.22 per share from the same period last year.

What type of business is Quest Diagnostics Incorporated?

Quest Diagnostics Incorporated is one of the leading providers of diagnostic services headquartered in Secaucus, New Jersey. The company specializes in diagnostics for cancer, cardiovascular and infectious diseases, as well as neurological disorders, COVID-19, and conducts forensic drug testing. It was founded in 1967 as Metropolitan Pathology Laboratory, Inc. The company's activities are divided into two directions: Diagnostic information services - provides diagnostic services and analytical data to a wide range of clients, including patients, physicians, hospitals, employers, and others. Diagnostic solutions - provides services for assessing risks in the life insurance industry.

What sector is Quest Diagnostics Incorporated in?

Quest Diagnostics Incorporated is in the Healthcare sector

What industry is Quest Diagnostics Incorporated in?

Quest Diagnostics Incorporated is in the Diagnostics & Research industry

What country is Quest Diagnostics Incorporated from?

Quest Diagnostics Incorporated is headquartered in United States

When did Quest Diagnostics Incorporated go public?

Quest Diagnostics Incorporated initial public offering (IPO) was on 17 December 1996

What is Quest Diagnostics Incorporated website?

https://www.questdiagnostics.com

Is Quest Diagnostics Incorporated in the S&P 500?

Yes, Quest Diagnostics Incorporated is included in the S&P 500 index

Is Quest Diagnostics Incorporated in the NASDAQ 100?

No, Quest Diagnostics Incorporated is not included in the NASDAQ 100 index

Is Quest Diagnostics Incorporated in the Dow Jones?

No, Quest Diagnostics Incorporated is not included in the Dow Jones index

When was Quest Diagnostics Incorporated the previous earnings report?

No data

When does Quest Diagnostics Incorporated earnings report?

The next expected earnings date for Quest Diagnostics Incorporated is 31 January 2025